NovaBay Pharmaceuticals, Inc. 4
4 · NovaBay Pharmaceuticals, Inc. · Filed May 13, 2016
Insider Transaction Report
Form 4
SIECZKAREK MARK M
Director
Transactions
- Award
Warrant
2016-05-09+130,890→ 142,557 totalExercise: $1.91From: 2016-05-09Exp: 2020-05-05→ Common Stock (130,890 underlying)
Footnotes (1)
- [F1]Warrant acquisition pursuant to a securities purchase agreement, which is one of a series of securities purchase agreements that the company entered into for the sale of an aggregate of 2,039,530 warrants to 9 accredited investors. The company expects to sell another 1,047,121 warrants pursuant to those same agreements on July 31, 2016.